Full Text
PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

Abstract

Authors

G Dranitsaris I Truter M Lubbe B Spirovski W Cottrell J Edwards

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×